BREZTRI AEROSPHERE
BREZTRI AEROSPHERE
Approved
DIN Number
02518058
Drug Class
Human
Market Date
Dec 3, 2021
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518058
AIG Number0363070002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AL11 FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE
Product Specifications
Dosage FormAerosol, Metered Dose
Route of AdministrationInhalation
AHFS Classification12:08.08
Health Canada Classification
ACTIVE INGREDIENTS (3)
BUDESONIDEActive
Strength: 160 MCG / ACT
Monograph: BUDESONIDE
FORMOTEROL FUMARATE DIHYDRATEActive
Strength: 5 MCG / ACT
Monograph: FORMOTEROL FUMARATE DIHYDRATE
GLYCOPYRRONIUM (GLYCOPYRROLATE)Active
Strength: 7.2 MCG / ACT
Monograph: GLYCOPYRRONIUM (GLYCOPYRROLATE)